216 related articles for article (PubMed ID: 28192263)
21. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
Velat GJ; Kimball MM; Mocco JD; Hoh BL
World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
[TBL] [Abstract][Full Text] [Related]
22. Tirilazad for aneurysmal subarachnoid haemorrhage.
Zhang S; Wang L; Liu M; Wu B
Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S
Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
[TBL] [Abstract][Full Text] [Related]
24. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Kumar G; Shahripour RB; Harrigan MR
J Neurosurg; 2016 May; 124(5):1257-64. PubMed ID: 26495942
[TBL] [Abstract][Full Text] [Related]
25. Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.
Naraoka M; Matsuda N; Shimamura N; Asano K; Akasaka K; Takemura A; Hasegawa S; Ohkuma H
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1190-1198. PubMed ID: 28762878
[TBL] [Abstract][Full Text] [Related]
26. Statins in the management of aneurysmal subarachnoid hemorrhage: an overview of animal research, observational studies, randomized controlled trials and meta-analyses.
Kramer AH
Acta Neurochir Suppl; 2011; 110(Pt 2):193-201. PubMed ID: 21125471
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shan T; Zhang T; Qian W; Ma L; Li H; You C; Xie X
J Neurol; 2020 Jun; 267(6):1577-1584. PubMed ID: 30739182
[TBL] [Abstract][Full Text] [Related]
28. Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Rosalind Lai PM; Du R
World Neurosurg; 2015 Oct; 84(4):933-41.e2. PubMed ID: 26074429
[TBL] [Abstract][Full Text] [Related]
29. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis.
Cho SS; Kim SE; Kim HC; Kim WJ; Jeon JP
World Neurosurg; 2019 Mar; 123():418-424.e3. PubMed ID: 30508597
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials.
Ma J; Huang S; Ma L; Liu Y; Li H; You C
Crit Care; 2012 Oct; 16(5):R198. PubMed ID: 23078672
[TBL] [Abstract][Full Text] [Related]
31. Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Kramer AH; Fletcher JJ
Neurocrit Care; 2010 Apr; 12(2):285-96. PubMed ID: 19921470
[TBL] [Abstract][Full Text] [Related]
32. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.
Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL
Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage.
Liu GJ; Luo J; Zhang LP; Wang ZJ; Xu LL; He GH; Zeng YJ; Wang YF
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):834-44. PubMed ID: 21999736
[TBL] [Abstract][Full Text] [Related]
34. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Kramer AH; Fletcher JJ
Neurocrit Care; 2011 Jun; 14(3):489-99. PubMed ID: 20740327
[TBL] [Abstract][Full Text] [Related]
35. Effect of statins on functional outcome and mortality following aneurysmal subarachnoid hemorrhage - Results of a meta-analysis, metaregression and trial sequential analysis.
Bohara S; Gaonkar VB; Garg K; Rajpal PMS; Singh PK; Singh M; Suri A; Chandra PS; Kale SS
Clin Neurol Neurosurg; 2021 Aug; 207():106787. PubMed ID: 34225002
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Reddy D; Fallah A; Petropoulos JA; Farrokhyar F; Macdonald RL; Jichici D
Neurocrit Care; 2014 Oct; 21(2):356-64. PubMed ID: 24619389
[TBL] [Abstract][Full Text] [Related]
37. Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Trimble JL; Kockler DR
Ann Pharmacother; 2007 Dec; 41(12):2019-23. PubMed ID: 17986515
[TBL] [Abstract][Full Text] [Related]
38. Cilostazol Administration for Subarachnoid Hemorrhage: A Meta-analysis of Randomized Controlled Trials.
Chen H; Luo W; Cai X; Cai J
Clin Neuropharmacol; 2022 Sep-Oct 01; 45(5):111-116. PubMed ID: 36162042
[TBL] [Abstract][Full Text] [Related]
39. Effect of statins treatment for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Liu J; Chen Q
Int J Clin Exp Med; 2015; 8(5):7198-208. PubMed ID: 26221259
[TBL] [Abstract][Full Text] [Related]
40. Beta-Blockade in Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-Analysis.
Ramesh AV; Banks CFK; Mounstephen PE; Crewdson K; Thomas M
Neurocrit Care; 2020 Oct; 33(2):508-515. PubMed ID: 31993953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
